These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21599979)

  • 1. Inhibition of hepatitis C virus 3a genotype entry through Glanthus Nivalis Agglutinin.
    Ashfaq UA; Masoud MS; Khaliq S; Nawaz Z; Riazuddin S
    Virol J; 2011 May; 8():248. PubMed ID: 21599979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.
    Kachko A; Loesgen S; Shahzad-Ul-Hussan S; Tan W; Zubkova I; Takeda K; Wells F; Rubin S; Bewley CA; Major ME
    Mol Pharm; 2013 Dec; 10(12):4590-4602. PubMed ID: 24152340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomotropic agents as HCV entry inhibitors.
    Ashfaq UA; Javed T; Rehman S; Nawaz Z; Riazuddin S
    Virol J; 2011 Apr; 8():163. PubMed ID: 21481279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies.
    Ashfaq UA; Qasim M; Yousaf MZ; Awan MT; Jahan S
    J Transl Med; 2011 Nov; 9():194. PubMed ID: 22074322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.
    Das S; Shetty RK; Kumar A; Shridharan RN; Tatineni R; Chi G; Mukherjee A; Das S; Subbarao SM; Karande AA
    PLoS One; 2013; 8(1):e53619. PubMed ID: 23341957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus.
    Wahyuni TS; Tumewu L; Permanasari AA; Apriani E; Adianti M; Rahman A; Widyawaruyanti A; Lusida MI; Fuad A; Soetjipto ; Nasronudin ; Fuchino H; Kawahara N; Shoji I; Deng L; Aoki C; Hotta H
    Virol J; 2013 Aug; 10():259. PubMed ID: 24089993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein.
    Hung TC; Jassey A; Liu CH; Lin CJ; Lin CC; Wong SH; Wang JY; Yen MH; Lin LT
    Phytomedicine; 2019 Feb; 53():62-69. PubMed ID: 30668413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
    Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
    Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.
    Brown KS; Keogh MJ; Owsianka AM; Adair R; Patel AH; Arnold JN; Ball JK; Sim RB; Tarr AW; Hickling TP
    Protein Cell; 2010 Jul; 1(7):664-74. PubMed ID: 21203938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methanolic Extract of
    Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
    Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
    Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.
    Coburn GA; Fisch DN; Moorji SM; de Muys JM; Murga JD; Paul D; Provoncha KP; Rotshteyn Y; Han AQ; Qian D; Maddon PJ; Olson WC
    PLoS One; 2012; 7(4):e35351. PubMed ID: 22545104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.
    Yin P; Zhang L; Ye F; Deng Y; Lu S; Li YP; Zhang L; Tan W
    Sci Rep; 2017 Jun; 7(1):3976. PubMed ID: 28638089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans.
    Helle F; Wychowski C; Vu-Dac N; Gustafson KR; Voisset C; Dubuisson J
    J Biol Chem; 2006 Sep; 281(35):25177-83. PubMed ID: 16809348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
    Schvoerer E; Moenne-Loccoz R; Murray JM; Velay A; Turek M; Fofana I; Fafi-Kremer S; Erba AC; Habersetzer F; Doffoël M; Gut JP; Donlin MJ; Tavis JE; Zeisel MB; Stoll-Keller F; Baumert TF
    J Infect Dis; 2013 Apr; 207(8):1306-15. PubMed ID: 23335805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells.
    Basu A; Kanda T; Beyene A; Saito K; Meyer K; Ray R
    J Virol; 2007 Apr; 81(8):3933-41. PubMed ID: 17287282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of peptides that bind hepatitis C virus envelope protein E2 and inhibit viral cellular entry from a phage-display peptide library.
    Lü X; Yao M; Zhang JM; Yang J; Lei YF; Huang XJ; Jia ZS; Ma L; Lan HY; Xu ZK; Yin W
    Int J Mol Med; 2014 May; 33(5):1312-8. PubMed ID: 24573486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.